Actively Recruiting

Phase 1
Age: 3Years - 17Years
All Genders
Healthy Volunteers
NCT06376331

Washed Microbiota Transplantation for Attention-deficit/Hyperactivity Disorder

Led by The Second Hospital of Nanjing Medical University · Updated on 2025-09-05

50

Participants Needed

2

Research Sites

165 weeks

Total Duration

On this page

Sponsors

T

The Second Hospital of Nanjing Medical University

Lead Sponsor

N

Nanjing Medical University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by inattention and hyperactivity-impulsivity. ADHD is often accompanied by oppositional defiant disorder and sleep disturbance, and can increase the risk of other psychiatric disorders, functional impairment in academic and occupational performance. Recently, gut microbiota has been implicated in the ADHD via gut-brain axis. In this study, investigators aimed to evaluate the efficacy of WMT for core ADHD symptoms and its comorbidities using specialized questionnaires for ADHD and investigate the underlying mechanism.

CONDITIONS

Official Title

Washed Microbiota Transplantation for Attention-deficit/Hyperactivity Disorder

Who Can Participate

Age: 3Years - 17Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Children diagnosed with ADHD according to the Diagnostic And Statistical Manual of Mental Disorders Fifth Edition
  • Aged between 3 and 17 years
  • Receiving stable ADHD treatments for at least 1 month before WMT
  • No use of antibiotics or probiotics affecting gut microbiota in the 3 months before WMT
Not Eligible

You will not qualify if you...

  • Unable to understand questionnaires or provide informed consent by guardian
  • Diagnosed with single-gene disorder, psychosis, central nervous system diseases, or gastrointestinal diseases such as ulcerative colitis, Crohn's disease, celiac disease, or eosinophilic esophagitis
  • Having severe comorbidities including heart or lung failure, severe liver or kidney disease, or cancer
  • Having other life-threatening disorders requiring emergency treatment
  • Unable to tolerate colonoscopy or anesthesia

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Department of Microbiota Medicine & Medical Centre for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, China

Actively Recruiting

2

SIR RUN RUN hospital of Nanjing Medical University

Nanjing, Jiangsu, China

Actively Recruiting

Loading map...

Research Team

F

Faming Zhang, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here